uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Ariclaim
Withdrawn
Human
Details
EMA number
EMEA/H/C/000552
ATC code
N06AX21
Authorisation
11 August 2004
Withdrawn
9 July 2018
Revision
26
EMA page
Therapeutic indication
Treatment of diabetic peripheral neuropathic pain. Ariclaim is indicated in adults.
MeSH:
Diabetic Neuropathies
Group:
Psychoanaleptics
Active substances
duloxetine
Marketing Authorisation Holder
Eli Lilly Nederland B.V.
MAH
Timeline
Filter by authority:
EMA
Ariclaim withdrawn
9 Jul 2018
withdrawn
regulatory
Ariclaim authorised
11 Aug 2004
authorised
regulatory
Ariclaim | uMedical